Corrigendum: Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study

• Sergio Serrano-Villar,
• Sergio Serrano-Villar,
• Calvin Cohen,
• Jason V. Baker,
• Jason V. Baker,
• Maria João Janeiro,
• Filipa Aragão,
• Filipa Aragão,
• Filipa Aragão,
• Kathleen Melbourne,
• Jose Luis Gonzalez,
• Laura Lara,
• Connie Kim,
• Santiago Moreno,
• Santiago Moreno,
• Santiago Moreno

Affiliations

Sergio Serrano-Villar

Hospital Universitario Ramón y Cajal, Infectious Diseases, Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain

Sergio Serrano-Villar

CIBERInfec, Instituto de Salud Carlos III, Madrid, Spain

Calvin Cohen

HIV Medical Affairs, Gilead Sciences Inc., Foster City, CA, United States

Jason V. Baker

Division of Infectious Diseases, Hennepin Healthcare Research Institute, Minneapolis, MN, United States

Jason V. Baker

Department of Medicine, University of Minnesota, Minneapolis, MN, United States

Maria João Janeiro

Maple Health Group, New York, NY, United States

Filipa Aragão

Maple Health Group, New York, NY, United States

Filipa Aragão

Incremental Action Consulting Lda, Lisbon, Portugal

Filipa Aragão

NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal

Kathleen Melbourne

HIV Medical Affairs, Gilead Sciences Inc., Foster City, CA, United States

Jose Luis Gonzalez

HIV Medical Affairs, Gilead Sciences Inc., Madrid, Spain

Laura Lara

HIV Medical Affairs, Gilead Sciences Inc., Madrid, Spain

Connie Kim

HIV Medical Affairs, Gilead Sciences Inc., Foster City, CA, United States

Santiago Moreno

Hospital Universitario Ramón y Cajal, Infectious Diseases, Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain

Santiago Moreno

CIBERInfec, Instituto de Salud Carlos III, Madrid, Spain

Santiago Moreno

0Department of Medicine, Alcalá University, Madrid, Spain